The Blue Biotechnology (BBt) sector has significant potential to positively influence the environment, human well-being and economic growth, however, in the Mediterranean basin, it is still in its infancy. The B-Blue project established a preliminary network of key actors in the field of BBt and conducted an in-depth analysis on best practices, drivers, barriers and requirements for EuroMed companies to adopt blue biotechnologies. This study has identified the most promising value chains for the EuroMed area.
As a result, 5 interactive Blue Biotechnology Hubs (BHHs) have been established to facilitate collaboration, knowledge transfer and synergistic impacts to stimulate innovation and business in the marine biotechnology sector. In addition, a digital community has been developed using an ICT tool called B-Blue MatchMaking Tool to support new collaborative initiatives. The MedIA – Mediterranean Innovation Alliance for Sustainable BlueBioeconomy was also established in collaboration with Blue Bio Med and two specific collaborative working groups on BBt.
The 2B-Blue project aims to capitalize on the positive results obtained by B-Blue in four main areas:
- Example of best practices identified to assist communities in applying BBt research;
- Creation of national demonstration sites (DS) to test emerging technologies or practices in local conditions, reducing the gap between research and the BBt industry and contributing to the improvement of the marine environment;
- Establish five-level strategic alliances to promote the advanced adoption of blue biotechnologies by Mediterranean industries;
- Improve regional policies to increase sustainability, research capacity and innovation in the Euro-Med area.
The main challenges identified in B-Blue’s work, in particular those related to financing, regulation and public-private collaboration, can be transformed into opportunities through 2B-Blue, leading to more sustainable and efficient practices and better structuring of the sector BBt in the Mediterranean.